Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sublingual Methadone for the Management of Cancer Breakthrough Pain

This study has been completed.
Calgary Health Region
Information provided by:
AHS Cancer Control Alberta Identifier:
First received: July 29, 2005
Last updated: January 18, 2012
Last verified: August 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)